HBM Healthcare Investments (Cayman) Ltd.
CIK 1232258 · last filed 2023-02-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$311.06M
Companies
9
Total Filings
54
Lifetime Open-Market Net
-$16.37M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MLYS | 10%+ Owner | 3,218,106 | $23.62 | $76.01M | $5.00M | 1 | 2023-02-16 |
| IO Biotech, Inc. (IOBT) Delisted | 10%+ Owner | 2,365,545 | $0.05 | $113.5K | $4.55M | 1 | 2021-11-12 |
| HOWL | 10%+ Owner | 625,995 | $0.38 | $238.5K | $0 | 1 | 2021-05-05 |
| Nabriva Therapeutics plc (NBRV) Delisted | 10%+ Owner | 2,334,128 | $1.42 | $3.31M | -$4.13M | 15 | 2017-09-14 |
| Paratek Pharmaceuticals, Inc. (PRTK) Delisted | 10%+ Owner | 1,757,680 | $2.23 | $3.92M | -$632.9K | 1 | 2015-06-01 |
| PTCT | 10%+ Owner | 2,441,504 | $75.14 | $183.45M | $8.73M | 2 | 2013-12-19 |
| IVERIC bio, Inc. (OPHT) Delisted | 10%+ Owner | 2,806,937 | — | — | $5.02M | 1 | 2013-10-03 |
| PCRX | 10%+ Owner | 2,233,993 | $22.99 | $51.36M | -$27.84M | 4 | 2013-03-25 |
| MICRUS ENDOVASCULAR CORP (MEND) Delisted | 10%+ Owner | 1,635,403 | — | — | -$7.06M | 24 | 2010-03-04 |
Recent Filings · Page 2 of 6
54 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-07-18 | — | Sell (S) | −69,854 | -$734.3K | |
| 2017-07-13 | — | Sell (S) | −57,175 | -$602.1K | |
| 2017-07-07 | — | Sell (S) | −2,695 | -$28.4K | |
| 2017-07-05 | Nabriva Therapeutics plc (NBRV) Delisted | Sell (S) | −13,127 | -$143.7K | EDGAR |
| 2017-06-29 | Nabriva Therapeutics plc (NBRV) Delisted | Sell (S) | −8,558 | -$93.8K | EDGAR |
| 2017-06-05 | Nabriva Therapeutics plc (NBRV) Delisted | Sell (S) | −400 | -$4.5K | EDGAR |
| 2017-04-28 | Nabriva Therapeutics plc (NBRV) Delisted | Sell (S) | −15,939 | -$175.7K | EDGAR |
| 2017-04-25 | Nabriva Therapeutics plc (NBRV) Delisted | Sell (S) | −2,622 | -$28.9K | EDGAR |
| 2017-04-20 | Nabriva Therapeutics plc (NBRV) Delisted | Sell (S) | −23,932 | -$265.9K | EDGAR |
| 2017-04-13 | Nabriva Therapeutics plc (NBRV) Delisted | Sell (S) | −32,831 | -$368.9K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.